Gene · 80310
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway. | Food Chem Toxicol | 2021 | 33561516 | PubTator, text mining | PubMed |
| First trimester placental mesenchymal stem cells improve cardiac function of rat after myocardial infarction via enhanced neovascularization. | Heliyon | 2021 | 33553765 | PubTator, text mining | PubMed |
| Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy. | Cancers (Basel) | 2021 | 33546248 | PubTator, text mining | PubMed |
| Alcohol Intake and Alcohol-SNP Interactions Associated with Prostate Cancer Aggressiveness. | J Clin Med | 2021 | 33540941 | PubTator, text mining | PubMed |
| Global transcriptomic analysis reveals Lnc-ADAMTS9 exerting an essential role in myogenesis through modulating the ERK signaling pathway. | J Anim Sci Biotechnol | 2021 | 33526083 | PubTator, text mining | PubMed |
| Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas. | ESMO Open | 2021 | 33524869 | PubTator, text mining | PubMed |
| Exosomes Released from CaSR-Stimulated PMNs Reduce Ischaemia/Reperfusion Injury. | Oxid Med Cell Longev | 2021 | 33505580 | PubTator, text mining | PubMed |
| Economical and easily detectable markers of digestive tumors: platelet parameters. | Biomark Med | 2021 | 33474972 | PubTator, text mining | PubMed |
| Autocrine Signaling in Cardiac Remodeling: A Rich Source of Therapeutic Targets. | J Am Heart Assoc | 2021 | 33470124 | PubTator, text mining | PubMed |
| Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database. | Aging (Albany NY) | 2021 | 33465047 | PubTator, text mining | PubMed |
| Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells. | Eur J Pharmacol | 2021 | 33460613 | PubTator, text mining | PubMed |
| New physiological insights into the phenomena of deer antler: A unique model for skeletal tissue regeneration. | J Orthop Translat | 2021 | 33437638 | PubTator, text mining | PubMed |
| Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer. | Aging (Albany NY) | 2021 | 33428596 | PubTator, text mining | PubMed |
| Differential expression profiles of long noncoding RNAs and mRNAs in human bone marrow mesenchymal stem cells after exposure to a high dosage of dexamethasone. | Stem Cell Res Ther | 2021 | 33407832 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy. | Expert Opin Investig Drugs | 2021 | 33322977 | PubTator, text mining | PubMed |
| Application of quantitative transcriptomics in evaluating the ex vivo effects of per- and polyfluoroalkyl substances on Atlantic cod (Gadus morhua) ovarian physiology. | Sci Total Environ | 2021 | 33138996 | PubTator, text mining | PubMed |
| Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions - An in-silico study. | Placenta | 2021 | 33126048 | PubTator, text mining | PubMed |
| HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia. | Exp Hematol | 2021 | 33069783 | PubTator, text mining | PubMed |
| SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling. | J Exp Med | 2021 | 33045063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/papers?page=30